Medical Care
Global Mesenchymal Stem Cells Market Research Report 2025
- May 12, 25
- ID: 243423
- Pages: 86
- Figures: 81
- Views: 2
The global market for Mesenchymal Stem Cells was valued at US$ 226 million in the year 2024 and is projected to reach a revised size of US$ 306 million by 2031, growing at a CAGR of 4.5% during the forecast period.
Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.
The top 3 manufacturters of Mesenchymal Stem Cells include Lonza, Thermo Fisher and Bio-Techne, with about 56% market shares.
North America region is the largest consumption of Mesenchymal Stem Cells, with a sales revenue market share nearly 41%. Europe is the second largest consumer of Mesenchymal Stem Cells, enjoying sales revenue market share about 31%.
This report aims to provide a comprehensive presentation of the global market for Mesenchymal Stem Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesenchymal Stem Cells.
The Mesenchymal Stem Cells market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mesenchymal Stem Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mesenchymal Stem Cells companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Thermo Fisher
Bio-Techne
ATCC
MilliporeSigma
PromoCell GmbH
Genlantis
Celprogen
Cell Applications
Cyagen Biosciences
Axol Bioscience
Segment by Type
Human MSC
Mouse MSC
Rat MSC
Others
Segment by Application
Research Institute
Hospital
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mesenchymal Stem Cells company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.
The top 3 manufacturters of Mesenchymal Stem Cells include Lonza, Thermo Fisher and Bio-Techne, with about 56% market shares.
North America region is the largest consumption of Mesenchymal Stem Cells, with a sales revenue market share nearly 41%. Europe is the second largest consumer of Mesenchymal Stem Cells, enjoying sales revenue market share about 31%.
This report aims to provide a comprehensive presentation of the global market for Mesenchymal Stem Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesenchymal Stem Cells.
The Mesenchymal Stem Cells market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mesenchymal Stem Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mesenchymal Stem Cells companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Thermo Fisher
Bio-Techne
ATCC
MilliporeSigma
PromoCell GmbH
Genlantis
Celprogen
Cell Applications
Cyagen Biosciences
Axol Bioscience
Segment by Type
Human MSC
Mouse MSC
Rat MSC
Others
Segment by Application
Research Institute
Hospital
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mesenchymal Stem Cells company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mesenchymal Stem Cells Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Human MSC
1.2.3 Mouse MSC
1.2.4 Rat MSC
1.2.5 Others
1.3 Market by Application
1.3.1 Global Mesenchymal Stem Cells Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Research Institute
1.3.3 Hospital
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mesenchymal Stem Cells Market Perspective (2020-2031)
2.2 Global Mesenchymal Stem Cells Growth Trends by Region
2.2.1 Global Mesenchymal Stem Cells Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Mesenchymal Stem Cells Historic Market Size by Region (2020-2025)
2.2.3 Mesenchymal Stem Cells Forecasted Market Size by Region (2026-2031)
2.3 Mesenchymal Stem Cells Market Dynamics
2.3.1 Mesenchymal Stem Cells Industry Trends
2.3.2 Mesenchymal Stem Cells Market Drivers
2.3.3 Mesenchymal Stem Cells Market Challenges
2.3.4 Mesenchymal Stem Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mesenchymal Stem Cells Players by Revenue
3.1.1 Global Top Mesenchymal Stem Cells Players by Revenue (2020-2025)
3.1.2 Global Mesenchymal Stem Cells Revenue Market Share by Players (2020-2025)
3.2 Global Mesenchymal Stem Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Mesenchymal Stem Cells Revenue
3.4 Global Mesenchymal Stem Cells Market Concentration Ratio
3.4.1 Global Mesenchymal Stem Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mesenchymal Stem Cells Revenue in 2024
3.5 Global Key Players of Mesenchymal Stem Cells Head office and Area Served
3.6 Global Key Players of Mesenchymal Stem Cells, Product and Application
3.7 Global Key Players of Mesenchymal Stem Cells, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Mesenchymal Stem Cells Breakdown Data by Type
4.1 Global Mesenchymal Stem Cells Historic Market Size by Type (2020-2025)
4.2 Global Mesenchymal Stem Cells Forecasted Market Size by Type (2026-2031)
5 Mesenchymal Stem Cells Breakdown Data by Application
5.1 Global Mesenchymal Stem Cells Historic Market Size by Application (2020-2025)
5.2 Global Mesenchymal Stem Cells Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Mesenchymal Stem Cells Market Size (2020-2031)
6.2 North America Mesenchymal Stem Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Mesenchymal Stem Cells Market Size by Country (2020-2025)
6.4 North America Mesenchymal Stem Cells Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Mesenchymal Stem Cells Market Size (2020-2031)
7.2 Europe Mesenchymal Stem Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Mesenchymal Stem Cells Market Size by Country (2020-2025)
7.4 Europe Mesenchymal Stem Cells Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mesenchymal Stem Cells Market Size (2020-2031)
8.2 Asia-Pacific Mesenchymal Stem Cells Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Mesenchymal Stem Cells Market Size by Region (2020-2025)
8.4 Asia-Pacific Mesenchymal Stem Cells Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Mesenchymal Stem Cells Market Size (2020-2031)
9.2 Latin America Mesenchymal Stem Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Mesenchymal Stem Cells Market Size by Country (2020-2025)
9.4 Latin America Mesenchymal Stem Cells Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mesenchymal Stem Cells Market Size (2020-2031)
10.2 Middle East & Africa Mesenchymal Stem Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2020-2025)
10.4 Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Mesenchymal Stem Cells Introduction
11.1.4 Lonza Revenue in Mesenchymal Stem Cells Business (2020-2025)
11.1.5 Lonza Recent Development
11.2 Thermo Fisher
11.2.1 Thermo Fisher Company Details
11.2.2 Thermo Fisher Business Overview
11.2.3 Thermo Fisher Mesenchymal Stem Cells Introduction
11.2.4 Thermo Fisher Revenue in Mesenchymal Stem Cells Business (2020-2025)
11.2.5 Thermo Fisher Recent Development
11.3 Bio-Techne
11.3.1 Bio-Techne Company Details
11.3.2 Bio-Techne Business Overview
11.3.3 Bio-Techne Mesenchymal Stem Cells Introduction
11.3.4 Bio-Techne Revenue in Mesenchymal Stem Cells Business (2020-2025)
11.3.5 Bio-Techne Recent Development
11.4 ATCC
11.4.1 ATCC Company Details
11.4.2 ATCC Business Overview
11.4.3 ATCC Mesenchymal Stem Cells Introduction
11.4.4 ATCC Revenue in Mesenchymal Stem Cells Business (2020-2025)
11.4.5 ATCC Recent Development
11.5 MilliporeSigma
11.5.1 MilliporeSigma Company Details
11.5.2 MilliporeSigma Business Overview
11.5.3 MilliporeSigma Mesenchymal Stem Cells Introduction
11.5.4 MilliporeSigma Revenue in Mesenchymal Stem Cells Business (2020-2025)
11.5.5 MilliporeSigma Recent Development
11.6 PromoCell GmbH
11.6.1 PromoCell GmbH Company Details
11.6.2 PromoCell GmbH Business Overview
11.6.3 PromoCell GmbH Mesenchymal Stem Cells Introduction
11.6.4 PromoCell GmbH Revenue in Mesenchymal Stem Cells Business (2020-2025)
11.6.5 PromoCell GmbH Recent Development
11.7 Genlantis
11.7.1 Genlantis Company Details
11.7.2 Genlantis Business Overview
11.7.3 Genlantis Mesenchymal Stem Cells Introduction
11.7.4 Genlantis Revenue in Mesenchymal Stem Cells Business (2020-2025)
11.7.5 Genlantis Recent Development
11.8 Celprogen
11.8.1 Celprogen Company Details
11.8.2 Celprogen Business Overview
11.8.3 Celprogen Mesenchymal Stem Cells Introduction
11.8.4 Celprogen Revenue in Mesenchymal Stem Cells Business (2020-2025)
11.8.5 Celprogen Recent Development
11.9 Cell Applications
11.9.1 Cell Applications Company Details
11.9.2 Cell Applications Business Overview
11.9.3 Cell Applications Mesenchymal Stem Cells Introduction
11.9.4 Cell Applications Revenue in Mesenchymal Stem Cells Business (2020-2025)
11.9.5 Cell Applications Recent Development
11.10 Cyagen Biosciences
11.10.1 Cyagen Biosciences Company Details
11.10.2 Cyagen Biosciences Business Overview
11.10.3 Cyagen Biosciences Mesenchymal Stem Cells Introduction
11.10.4 Cyagen Biosciences Revenue in Mesenchymal Stem Cells Business (2020-2025)
11.10.5 Cyagen Biosciences Recent Development
11.11 Axol Bioscience
11.11.1 Axol Bioscience Company Details
11.11.2 Axol Bioscience Business Overview
11.11.3 Axol Bioscience Mesenchymal Stem Cells Introduction
11.11.4 Axol Bioscience Revenue in Mesenchymal Stem Cells Business (2020-2025)
11.11.5 Axol Bioscience Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mesenchymal Stem Cells Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Human MSC
1.2.3 Mouse MSC
1.2.4 Rat MSC
1.2.5 Others
1.3 Market by Application
1.3.1 Global Mesenchymal Stem Cells Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Research Institute
1.3.3 Hospital
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mesenchymal Stem Cells Market Perspective (2020-2031)
2.2 Global Mesenchymal Stem Cells Growth Trends by Region
2.2.1 Global Mesenchymal Stem Cells Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Mesenchymal Stem Cells Historic Market Size by Region (2020-2025)
2.2.3 Mesenchymal Stem Cells Forecasted Market Size by Region (2026-2031)
2.3 Mesenchymal Stem Cells Market Dynamics
2.3.1 Mesenchymal Stem Cells Industry Trends
2.3.2 Mesenchymal Stem Cells Market Drivers
2.3.3 Mesenchymal Stem Cells Market Challenges
2.3.4 Mesenchymal Stem Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mesenchymal Stem Cells Players by Revenue
3.1.1 Global Top Mesenchymal Stem Cells Players by Revenue (2020-2025)
3.1.2 Global Mesenchymal Stem Cells Revenue Market Share by Players (2020-2025)
3.2 Global Mesenchymal Stem Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Mesenchymal Stem Cells Revenue
3.4 Global Mesenchymal Stem Cells Market Concentration Ratio
3.4.1 Global Mesenchymal Stem Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mesenchymal Stem Cells Revenue in 2024
3.5 Global Key Players of Mesenchymal Stem Cells Head office and Area Served
3.6 Global Key Players of Mesenchymal Stem Cells, Product and Application
3.7 Global Key Players of Mesenchymal Stem Cells, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Mesenchymal Stem Cells Breakdown Data by Type
4.1 Global Mesenchymal Stem Cells Historic Market Size by Type (2020-2025)
4.2 Global Mesenchymal Stem Cells Forecasted Market Size by Type (2026-2031)
5 Mesenchymal Stem Cells Breakdown Data by Application
5.1 Global Mesenchymal Stem Cells Historic Market Size by Application (2020-2025)
5.2 Global Mesenchymal Stem Cells Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Mesenchymal Stem Cells Market Size (2020-2031)
6.2 North America Mesenchymal Stem Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Mesenchymal Stem Cells Market Size by Country (2020-2025)
6.4 North America Mesenchymal Stem Cells Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Mesenchymal Stem Cells Market Size (2020-2031)
7.2 Europe Mesenchymal Stem Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Mesenchymal Stem Cells Market Size by Country (2020-2025)
7.4 Europe Mesenchymal Stem Cells Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mesenchymal Stem Cells Market Size (2020-2031)
8.2 Asia-Pacific Mesenchymal Stem Cells Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Mesenchymal Stem Cells Market Size by Region (2020-2025)
8.4 Asia-Pacific Mesenchymal Stem Cells Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Mesenchymal Stem Cells Market Size (2020-2031)
9.2 Latin America Mesenchymal Stem Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Mesenchymal Stem Cells Market Size by Country (2020-2025)
9.4 Latin America Mesenchymal Stem Cells Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mesenchymal Stem Cells Market Size (2020-2031)
10.2 Middle East & Africa Mesenchymal Stem Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2020-2025)
10.4 Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Mesenchymal Stem Cells Introduction
11.1.4 Lonza Revenue in Mesenchymal Stem Cells Business (2020-2025)
11.1.5 Lonza Recent Development
11.2 Thermo Fisher
11.2.1 Thermo Fisher Company Details
11.2.2 Thermo Fisher Business Overview
11.2.3 Thermo Fisher Mesenchymal Stem Cells Introduction
11.2.4 Thermo Fisher Revenue in Mesenchymal Stem Cells Business (2020-2025)
11.2.5 Thermo Fisher Recent Development
11.3 Bio-Techne
11.3.1 Bio-Techne Company Details
11.3.2 Bio-Techne Business Overview
11.3.3 Bio-Techne Mesenchymal Stem Cells Introduction
11.3.4 Bio-Techne Revenue in Mesenchymal Stem Cells Business (2020-2025)
11.3.5 Bio-Techne Recent Development
11.4 ATCC
11.4.1 ATCC Company Details
11.4.2 ATCC Business Overview
11.4.3 ATCC Mesenchymal Stem Cells Introduction
11.4.4 ATCC Revenue in Mesenchymal Stem Cells Business (2020-2025)
11.4.5 ATCC Recent Development
11.5 MilliporeSigma
11.5.1 MilliporeSigma Company Details
11.5.2 MilliporeSigma Business Overview
11.5.3 MilliporeSigma Mesenchymal Stem Cells Introduction
11.5.4 MilliporeSigma Revenue in Mesenchymal Stem Cells Business (2020-2025)
11.5.5 MilliporeSigma Recent Development
11.6 PromoCell GmbH
11.6.1 PromoCell GmbH Company Details
11.6.2 PromoCell GmbH Business Overview
11.6.3 PromoCell GmbH Mesenchymal Stem Cells Introduction
11.6.4 PromoCell GmbH Revenue in Mesenchymal Stem Cells Business (2020-2025)
11.6.5 PromoCell GmbH Recent Development
11.7 Genlantis
11.7.1 Genlantis Company Details
11.7.2 Genlantis Business Overview
11.7.3 Genlantis Mesenchymal Stem Cells Introduction
11.7.4 Genlantis Revenue in Mesenchymal Stem Cells Business (2020-2025)
11.7.5 Genlantis Recent Development
11.8 Celprogen
11.8.1 Celprogen Company Details
11.8.2 Celprogen Business Overview
11.8.3 Celprogen Mesenchymal Stem Cells Introduction
11.8.4 Celprogen Revenue in Mesenchymal Stem Cells Business (2020-2025)
11.8.5 Celprogen Recent Development
11.9 Cell Applications
11.9.1 Cell Applications Company Details
11.9.2 Cell Applications Business Overview
11.9.3 Cell Applications Mesenchymal Stem Cells Introduction
11.9.4 Cell Applications Revenue in Mesenchymal Stem Cells Business (2020-2025)
11.9.5 Cell Applications Recent Development
11.10 Cyagen Biosciences
11.10.1 Cyagen Biosciences Company Details
11.10.2 Cyagen Biosciences Business Overview
11.10.3 Cyagen Biosciences Mesenchymal Stem Cells Introduction
11.10.4 Cyagen Biosciences Revenue in Mesenchymal Stem Cells Business (2020-2025)
11.10.5 Cyagen Biosciences Recent Development
11.11 Axol Bioscience
11.11.1 Axol Bioscience Company Details
11.11.2 Axol Bioscience Business Overview
11.11.3 Axol Bioscience Mesenchymal Stem Cells Introduction
11.11.4 Axol Bioscience Revenue in Mesenchymal Stem Cells Business (2020-2025)
11.11.5 Axol Bioscience Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Mesenchymal Stem Cells Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Human MSC
Table 3. Key Players of Mouse MSC
Table 4. Key Players of Rat MSC
Table 5. Key Players of Others
Table 6. Global Mesenchymal Stem Cells Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Mesenchymal Stem Cells Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Mesenchymal Stem Cells Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Mesenchymal Stem Cells Market Share by Region (2020-2025)
Table 10. Global Mesenchymal Stem Cells Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Mesenchymal Stem Cells Market Share by Region (2026-2031)
Table 12. Mesenchymal Stem Cells Market Trends
Table 13. Mesenchymal Stem Cells Market Drivers
Table 14. Mesenchymal Stem Cells Market Challenges
Table 15. Mesenchymal Stem Cells Market Restraints
Table 16. Global Mesenchymal Stem Cells Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Mesenchymal Stem Cells Market Share by Players (2020-2025)
Table 18. Global Top Mesenchymal Stem Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesenchymal Stem Cells as of 2024)
Table 19. Ranking of Global Top Mesenchymal Stem Cells Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Mesenchymal Stem Cells Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Mesenchymal Stem Cells, Headquarters and Area Served
Table 22. Global Key Players of Mesenchymal Stem Cells, Product and Application
Table 23. Global Key Players of Mesenchymal Stem Cells, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Mesenchymal Stem Cells Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Mesenchymal Stem Cells Revenue Market Share by Type (2020-2025)
Table 27. Global Mesenchymal Stem Cells Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Mesenchymal Stem Cells Revenue Market Share by Type (2026-2031)
Table 29. Global Mesenchymal Stem Cells Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Mesenchymal Stem Cells Revenue Market Share by Application (2020-2025)
Table 31. Global Mesenchymal Stem Cells Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Mesenchymal Stem Cells Revenue Market Share by Application (2026-2031)
Table 33. North America Mesenchymal Stem Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Mesenchymal Stem Cells Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Mesenchymal Stem Cells Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Mesenchymal Stem Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Mesenchymal Stem Cells Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Mesenchymal Stem Cells Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Mesenchymal Stem Cells Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Mesenchymal Stem Cells Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Mesenchymal Stem Cells Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Mesenchymal Stem Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Mesenchymal Stem Cells Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Mesenchymal Stem Cells Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Mesenchymal Stem Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2026-2031) & (US$ Million)
Table 48. Lonza Company Details
Table 49. Lonza Business Overview
Table 50. Lonza Mesenchymal Stem Cells Product
Table 51. Lonza Revenue in Mesenchymal Stem Cells Business (2020-2025) & (US$ Million)
Table 52. Lonza Recent Development
Table 53. Thermo Fisher Company Details
Table 54. Thermo Fisher Business Overview
Table 55. Thermo Fisher Mesenchymal Stem Cells Product
Table 56. Thermo Fisher Revenue in Mesenchymal Stem Cells Business (2020-2025) & (US$ Million)
Table 57. Thermo Fisher Recent Development
Table 58. Bio-Techne Company Details
Table 59. Bio-Techne Business Overview
Table 60. Bio-Techne Mesenchymal Stem Cells Product
Table 61. Bio-Techne Revenue in Mesenchymal Stem Cells Business (2020-2025) & (US$ Million)
Table 62. Bio-Techne Recent Development
Table 63. ATCC Company Details
Table 64. ATCC Business Overview
Table 65. ATCC Mesenchymal Stem Cells Product
Table 66. ATCC Revenue in Mesenchymal Stem Cells Business (2020-2025) & (US$ Million)
Table 67. ATCC Recent Development
Table 68. MilliporeSigma Company Details
Table 69. MilliporeSigma Business Overview
Table 70. MilliporeSigma Mesenchymal Stem Cells Product
Table 71. MilliporeSigma Revenue in Mesenchymal Stem Cells Business (2020-2025) & (US$ Million)
Table 72. MilliporeSigma Recent Development
Table 73. PromoCell GmbH Company Details
Table 74. PromoCell GmbH Business Overview
Table 75. PromoCell GmbH Mesenchymal Stem Cells Product
Table 76. PromoCell GmbH Revenue in Mesenchymal Stem Cells Business (2020-2025) & (US$ Million)
Table 77. PromoCell GmbH Recent Development
Table 78. Genlantis Company Details
Table 79. Genlantis Business Overview
Table 80. Genlantis Mesenchymal Stem Cells Product
Table 81. Genlantis Revenue in Mesenchymal Stem Cells Business (2020-2025) & (US$ Million)
Table 82. Genlantis Recent Development
Table 83. Celprogen Company Details
Table 84. Celprogen Business Overview
Table 85. Celprogen Mesenchymal Stem Cells Product
Table 86. Celprogen Revenue in Mesenchymal Stem Cells Business (2020-2025) & (US$ Million)
Table 87. Celprogen Recent Development
Table 88. Cell Applications Company Details
Table 89. Cell Applications Business Overview
Table 90. Cell Applications Mesenchymal Stem Cells Product
Table 91. Cell Applications Revenue in Mesenchymal Stem Cells Business (2020-2025) & (US$ Million)
Table 92. Cell Applications Recent Development
Table 93. Cyagen Biosciences Company Details
Table 94. Cyagen Biosciences Business Overview
Table 95. Cyagen Biosciences Mesenchymal Stem Cells Product
Table 96. Cyagen Biosciences Revenue in Mesenchymal Stem Cells Business (2020-2025) & (US$ Million)
Table 97. Cyagen Biosciences Recent Development
Table 98. Axol Bioscience Company Details
Table 99. Axol Bioscience Business Overview
Table 100. Axol Bioscience Mesenchymal Stem Cells Product
Table 101. Axol Bioscience Revenue in Mesenchymal Stem Cells Business (2020-2025) & (US$ Million)
Table 102. Axol Bioscience Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Mesenchymal Stem Cells Picture
Figure 2. Global Mesenchymal Stem Cells Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Mesenchymal Stem Cells Market Share by Type: 2024 VS 2031
Figure 4. Human MSC Features
Figure 5. Mouse MSC Features
Figure 6. Rat MSC Features
Figure 7. Others Features
Figure 8. Global Mesenchymal Stem Cells Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Mesenchymal Stem Cells Market Share by Application: 2024 VS 2031
Figure 10. Research Institute Case Studies
Figure 11. Hospital Case Studies
Figure 12. Others Case Studies
Figure 13. Mesenchymal Stem Cells Report Years Considered
Figure 14. Global Mesenchymal Stem Cells Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Mesenchymal Stem Cells Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Mesenchymal Stem Cells Market Share by Region: 2024 VS 2031
Figure 17. Global Mesenchymal Stem Cells Market Share by Players in 2024
Figure 18. Global Top Mesenchymal Stem Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesenchymal Stem Cells as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Mesenchymal Stem Cells Revenue in 2024
Figure 20. North America Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Mesenchymal Stem Cells Market Share by Country (2020-2031)
Figure 22. United States Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Mesenchymal Stem Cells Market Share by Country (2020-2031)
Figure 26. Germany Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Mesenchymal Stem Cells Market Share by Region (2020-2031)
Figure 34. China Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Mesenchymal Stem Cells Market Share by Country (2020-2031)
Figure 42. Mexico Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Mesenchymal Stem Cells Market Share by Country (2020-2031)
Figure 46. Turkey Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Lonza Revenue Growth Rate in Mesenchymal Stem Cells Business (2020-2025)
Figure 50. Thermo Fisher Revenue Growth Rate in Mesenchymal Stem Cells Business (2020-2025)
Figure 51. Bio-Techne Revenue Growth Rate in Mesenchymal Stem Cells Business (2020-2025)
Figure 52. ATCC Revenue Growth Rate in Mesenchymal Stem Cells Business (2020-2025)
Figure 53. MilliporeSigma Revenue Growth Rate in Mesenchymal Stem Cells Business (2020-2025)
Figure 54. PromoCell GmbH Revenue Growth Rate in Mesenchymal Stem Cells Business (2020-2025)
Figure 55. Genlantis Revenue Growth Rate in Mesenchymal Stem Cells Business (2020-2025)
Figure 56. Celprogen Revenue Growth Rate in Mesenchymal Stem Cells Business (2020-2025)
Figure 57. Cell Applications Revenue Growth Rate in Mesenchymal Stem Cells Business (2020-2025)
Figure 58. Cyagen Biosciences Revenue Growth Rate in Mesenchymal Stem Cells Business (2020-2025)
Figure 59. Axol Bioscience Revenue Growth Rate in Mesenchymal Stem Cells Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Mesenchymal Stem Cells Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Human MSC
Table 3. Key Players of Mouse MSC
Table 4. Key Players of Rat MSC
Table 5. Key Players of Others
Table 6. Global Mesenchymal Stem Cells Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Mesenchymal Stem Cells Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Mesenchymal Stem Cells Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Mesenchymal Stem Cells Market Share by Region (2020-2025)
Table 10. Global Mesenchymal Stem Cells Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Mesenchymal Stem Cells Market Share by Region (2026-2031)
Table 12. Mesenchymal Stem Cells Market Trends
Table 13. Mesenchymal Stem Cells Market Drivers
Table 14. Mesenchymal Stem Cells Market Challenges
Table 15. Mesenchymal Stem Cells Market Restraints
Table 16. Global Mesenchymal Stem Cells Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Mesenchymal Stem Cells Market Share by Players (2020-2025)
Table 18. Global Top Mesenchymal Stem Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesenchymal Stem Cells as of 2024)
Table 19. Ranking of Global Top Mesenchymal Stem Cells Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Mesenchymal Stem Cells Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Mesenchymal Stem Cells, Headquarters and Area Served
Table 22. Global Key Players of Mesenchymal Stem Cells, Product and Application
Table 23. Global Key Players of Mesenchymal Stem Cells, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Mesenchymal Stem Cells Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Mesenchymal Stem Cells Revenue Market Share by Type (2020-2025)
Table 27. Global Mesenchymal Stem Cells Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Mesenchymal Stem Cells Revenue Market Share by Type (2026-2031)
Table 29. Global Mesenchymal Stem Cells Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Mesenchymal Stem Cells Revenue Market Share by Application (2020-2025)
Table 31. Global Mesenchymal Stem Cells Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Mesenchymal Stem Cells Revenue Market Share by Application (2026-2031)
Table 33. North America Mesenchymal Stem Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Mesenchymal Stem Cells Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Mesenchymal Stem Cells Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Mesenchymal Stem Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Mesenchymal Stem Cells Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Mesenchymal Stem Cells Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Mesenchymal Stem Cells Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Mesenchymal Stem Cells Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Mesenchymal Stem Cells Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Mesenchymal Stem Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Mesenchymal Stem Cells Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Mesenchymal Stem Cells Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Mesenchymal Stem Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2026-2031) & (US$ Million)
Table 48. Lonza Company Details
Table 49. Lonza Business Overview
Table 50. Lonza Mesenchymal Stem Cells Product
Table 51. Lonza Revenue in Mesenchymal Stem Cells Business (2020-2025) & (US$ Million)
Table 52. Lonza Recent Development
Table 53. Thermo Fisher Company Details
Table 54. Thermo Fisher Business Overview
Table 55. Thermo Fisher Mesenchymal Stem Cells Product
Table 56. Thermo Fisher Revenue in Mesenchymal Stem Cells Business (2020-2025) & (US$ Million)
Table 57. Thermo Fisher Recent Development
Table 58. Bio-Techne Company Details
Table 59. Bio-Techne Business Overview
Table 60. Bio-Techne Mesenchymal Stem Cells Product
Table 61. Bio-Techne Revenue in Mesenchymal Stem Cells Business (2020-2025) & (US$ Million)
Table 62. Bio-Techne Recent Development
Table 63. ATCC Company Details
Table 64. ATCC Business Overview
Table 65. ATCC Mesenchymal Stem Cells Product
Table 66. ATCC Revenue in Mesenchymal Stem Cells Business (2020-2025) & (US$ Million)
Table 67. ATCC Recent Development
Table 68. MilliporeSigma Company Details
Table 69. MilliporeSigma Business Overview
Table 70. MilliporeSigma Mesenchymal Stem Cells Product
Table 71. MilliporeSigma Revenue in Mesenchymal Stem Cells Business (2020-2025) & (US$ Million)
Table 72. MilliporeSigma Recent Development
Table 73. PromoCell GmbH Company Details
Table 74. PromoCell GmbH Business Overview
Table 75. PromoCell GmbH Mesenchymal Stem Cells Product
Table 76. PromoCell GmbH Revenue in Mesenchymal Stem Cells Business (2020-2025) & (US$ Million)
Table 77. PromoCell GmbH Recent Development
Table 78. Genlantis Company Details
Table 79. Genlantis Business Overview
Table 80. Genlantis Mesenchymal Stem Cells Product
Table 81. Genlantis Revenue in Mesenchymal Stem Cells Business (2020-2025) & (US$ Million)
Table 82. Genlantis Recent Development
Table 83. Celprogen Company Details
Table 84. Celprogen Business Overview
Table 85. Celprogen Mesenchymal Stem Cells Product
Table 86. Celprogen Revenue in Mesenchymal Stem Cells Business (2020-2025) & (US$ Million)
Table 87. Celprogen Recent Development
Table 88. Cell Applications Company Details
Table 89. Cell Applications Business Overview
Table 90. Cell Applications Mesenchymal Stem Cells Product
Table 91. Cell Applications Revenue in Mesenchymal Stem Cells Business (2020-2025) & (US$ Million)
Table 92. Cell Applications Recent Development
Table 93. Cyagen Biosciences Company Details
Table 94. Cyagen Biosciences Business Overview
Table 95. Cyagen Biosciences Mesenchymal Stem Cells Product
Table 96. Cyagen Biosciences Revenue in Mesenchymal Stem Cells Business (2020-2025) & (US$ Million)
Table 97. Cyagen Biosciences Recent Development
Table 98. Axol Bioscience Company Details
Table 99. Axol Bioscience Business Overview
Table 100. Axol Bioscience Mesenchymal Stem Cells Product
Table 101. Axol Bioscience Revenue in Mesenchymal Stem Cells Business (2020-2025) & (US$ Million)
Table 102. Axol Bioscience Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Mesenchymal Stem Cells Picture
Figure 2. Global Mesenchymal Stem Cells Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Mesenchymal Stem Cells Market Share by Type: 2024 VS 2031
Figure 4. Human MSC Features
Figure 5. Mouse MSC Features
Figure 6. Rat MSC Features
Figure 7. Others Features
Figure 8. Global Mesenchymal Stem Cells Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Mesenchymal Stem Cells Market Share by Application: 2024 VS 2031
Figure 10. Research Institute Case Studies
Figure 11. Hospital Case Studies
Figure 12. Others Case Studies
Figure 13. Mesenchymal Stem Cells Report Years Considered
Figure 14. Global Mesenchymal Stem Cells Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Mesenchymal Stem Cells Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Mesenchymal Stem Cells Market Share by Region: 2024 VS 2031
Figure 17. Global Mesenchymal Stem Cells Market Share by Players in 2024
Figure 18. Global Top Mesenchymal Stem Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesenchymal Stem Cells as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Mesenchymal Stem Cells Revenue in 2024
Figure 20. North America Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Mesenchymal Stem Cells Market Share by Country (2020-2031)
Figure 22. United States Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Mesenchymal Stem Cells Market Share by Country (2020-2031)
Figure 26. Germany Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Mesenchymal Stem Cells Market Share by Region (2020-2031)
Figure 34. China Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Mesenchymal Stem Cells Market Share by Country (2020-2031)
Figure 42. Mexico Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Mesenchymal Stem Cells Market Share by Country (2020-2031)
Figure 46. Turkey Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Mesenchymal Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Lonza Revenue Growth Rate in Mesenchymal Stem Cells Business (2020-2025)
Figure 50. Thermo Fisher Revenue Growth Rate in Mesenchymal Stem Cells Business (2020-2025)
Figure 51. Bio-Techne Revenue Growth Rate in Mesenchymal Stem Cells Business (2020-2025)
Figure 52. ATCC Revenue Growth Rate in Mesenchymal Stem Cells Business (2020-2025)
Figure 53. MilliporeSigma Revenue Growth Rate in Mesenchymal Stem Cells Business (2020-2025)
Figure 54. PromoCell GmbH Revenue Growth Rate in Mesenchymal Stem Cells Business (2020-2025)
Figure 55. Genlantis Revenue Growth Rate in Mesenchymal Stem Cells Business (2020-2025)
Figure 56. Celprogen Revenue Growth Rate in Mesenchymal Stem Cells Business (2020-2025)
Figure 57. Cell Applications Revenue Growth Rate in Mesenchymal Stem Cells Business (2020-2025)
Figure 58. Cyagen Biosciences Revenue Growth Rate in Mesenchymal Stem Cells Business (2020-2025)
Figure 59. Axol Bioscience Revenue Growth Rate in Mesenchymal Stem Cells Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Krypton Flash Lamp Market Research Report 2025
May 12, 25
Global IR Halogen Lamp Market Research Report 2025
May 12, 25
Global Halogen IR Lamp Market Research Report 2025
May 12, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232